Effect of biologic therapy on radiological progression in rheumatoid arthritis: what does it add to methotrexate?

References

• JonesGHalbertJCrottyMShanahanEMBatterhamMAhernMThe effect of treatment on radiological progression in rheumatoid arthritis: a systematic review of randomized placebo-controlled trialsRheumatology (Oxford)20034261312509606
   PubMed Web of Science ®Google Scholar
• CohenJStatistical Power Analysis for Behavioral Sciences2nd edNew Jersey, NJLawrence Erlbaum1988
   Google Scholar
• ArnettFCEdworthySMBlochDAThe American Rheumatism Association 1987 Revised Criteria for the Classification of Rheumatoid ArthritisArthritis Rheum1988313153243358796
   PubMed Web of Science ®Google Scholar
• SackettDLOxmanADCochrane Collaboration HandbookOxford, UKThe Cochrane Collaboration1997
   Google Scholar
• BathonJMMartinRWFleischmannRMA comparison of etanercept and methotrexate in patients with early rheumatoid arthritisN Engl J Med20003431586159311096165
   PubMed Web of Science ®Google Scholar
• KlareskogLvan der HeijdeDde JagerJPTherapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trialLancet200436367568115001324
   PubMed Web of Science ®Google Scholar
• EmeryPBreedveldFCHallSComparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trialLancet200837237538218635256
   PubMed Web of Science ®Google Scholar
• KeystoneEHeijdeDMasonDJrCertolizumab pegol plus methotrexate is significantly more effective than placebo plus methotrexate in active rheumatoid arthritis: findings of a fifty-two-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group studyArthritis Rheum2008583319332918975346
   PubMed Web of Science ®Google Scholar
• KeystoneECCurtisJRFleischmannRMRapid improvement in the signs and symptoms of rheumatoid arthritis following certolizumab pegol treatment predicts better longterm outcomes: post-hoc analysis of a randomized controlled trialJ Rheumatol20113899099621362764
   PubMed Web of Science ®Google Scholar
• SmolenJLandeweRBMeasePEfficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. A randomised controlled trialAnn Rheum Dis20096879780419015207
   PubMed Web of Science ®Google Scholar
• KeystoneECKavanaughAFSharpJTRadiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trialArthritis Rheum2004501400141115146409
   PubMed Web of Science ®Google Scholar
• BreedveldFCWeismanMHKavanaughAFThe PREMIER study: a multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatmentArthritis Rheum200654263716385520
   PubMed Web of Science ®Google Scholar
• LipskyPEvan der HeijdeDMSt ClairEWInfliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study groupN Engl J Med20003431594160211096166
   PubMed Web of Science ®Google Scholar
• BreedveldFCEmeryPKeystoneEInfliximab in active early rheumatoid arthritisAnn Rheum Dis20046314915514722203
   PubMed Web of Science ®Google Scholar
• EmeryPFleischmannRvan der HeijdeDThe effects of golimumab on radiographic progression in rheumatoid arthritis: results of randomized controlled studies of golimumab before methotrexate therapy and golimumab after methotrexate therapyArthritis Rheum2011631200121021305524
   PubMed Web of Science ®Google Scholar
• CohenSBKeystoneEGenoveseMCContinued inhibition of structural damage over 2 years in patients with rheumatoid arthritis treated with rituximab in combination with methotrexateAnn Rheum Dis2010691158116120439295
   PubMed Web of Science ®Google Scholar
• TakPPRigbyWFRubbert-RothAInhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trialAnn Rheum Dis201170394620937671
   PubMed Web of Science ®Google Scholar
• NishimotoNHashimotoJMiyasakaNStudy of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumabAnn Rheum Dis2007661162116717485422
   PubMed Web of Science ®Google Scholar
• KremerJMBlancoRBrzoskoMTocilizumab inhibits structural joint damage in rheumatoid arthritis patients with inadequate responses to methotrexate: results from the double-blind treatment phase of a randomized placebo-controlled trial of tocilizumab safety and prevention of structural joint damage at one yearArthritis Rheum20116360962121360490
   PubMed Web of Science ®Google Scholar
• KremerJMGenantHKMorelandLWEffects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis: a randomized trialAnn Intern Med200614486587616785475
   PubMed Web of Science ®Google Scholar
• WesthovensRRoblesMXimenesACClinical efficacy and safety of abatacept in methotrexate-naive patients with early rheumatoid arthritis and poor prognostic factorsAnn Rheum Dis2009681870187719124524
   PubMed Web of Science ®Google Scholar
• van der HeijdeDKlareskogLRodriguez-ValverdeVComparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trialArthritis Rheum2006541063107416572441
   PubMed Web of Science ®Google Scholar
• CohenSBDoreRKLaneNEDenosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, Phase II clinical trialArthritis Rheum2008581299130918438830
   PubMed Web of Science ®Google Scholar
• DeodharADoreRKMandelDDenosumab-mediated increase in hand bone mineral density associated with decreased progression of bone erosion in rheumatoid arthritis patientsArthritis Care Res201062569574
   PubMed Web of Science ®Google Scholar
• ØstergaardMEmeryPConaghanPGSignificant improvement in synovitis, osteitis, and bone erosion following golimumab and methotrexate combination therapy as compared with methotrexate alone: a magnetic resonance imaging study of 318 methotrexatenaive rheumatoid arthritis patientsArthritis Rheum201163123712372222127693
   PubMed Web of Science ®Google Scholar
• DougadosMKisselKSheeranTAdding tocilizumab or switching to tocilizumab monotherapy in methotrexate inadequate responders: 24-week symptomatic and structural results of a 2-year randomised controlled strategy trial in rheumatoid arthritis (ACT-RAY)Ann Rheum Dis annrheumdis-2011-201282 Published Online First: 5 May 201210.1136/annrheumdis-2011-201282
   Google Scholar
• TaylorAJonesGBiologic monotherapy for the treatment of rheumatoid arthritisClin Investig2011112911300
   Google Scholar
• KorpelaMLaasonenLHannonenPRetardation of joint damage in patients with early rheumatoid arthritis by initial aggressive treatment with disease-modifying antirheumatic drugs: five-year experience from the FIN-RACo studyArthritis Rheum2004502072208115248204
   PubMed Web of Science ®Google Scholar
• ChoyEHSmithCMFarewellVFactorial randomised controlled trial of glucocorticoids and combination disease modifying drugs in early rheumatoid arthritisAnn Rheum Dis20086765666317768173
   PubMed Web of Science ®Google Scholar
• MorelandLWO’DellJRPaulusHEA randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early, aggressive rheumatoid arthritisArthritis Rheum4162012 [Epub ahead of print.]
   Web of Science ®Google Scholar